期刊文献+

常见心肌损伤标志物在急性心肌梗死诊断中的应用价值 被引量:41

Evaluation of common myocardial injury markers in the diagnosis of acute myocardial infarction
在线阅读 下载PDF
导出
摘要 目的评价4种常见心肌损伤标志物——心肌肌钙蛋白T(cTnT)、肌酸激酶同工酶(CK-MB)、肌红蛋白(MYO)、心脏型脂肪酸结合蛋白(H-FABP)在急性心肌梗死(AMI)中的临床诊疗价值。方法收集2017年1―12月该院以"急性胸痛"症状为主诉收住入院的200例患者,应用受试者工作特征(ROC)曲线评价各心肌损伤标志物单独及联合检测在AMI中的临床诊断性能。结果 (1)AMI组cTnT、CK-MB、MYO、HFABP分别为0.162(0.027~0.457)μg/L、14.660(8.570~17.630)μg/L、149.000(68.000~234.000)μg/L、(6.330±1.990)ng/L,与非AMI组[0.007(0.005~0.010)μg/L、1.650(1.220~3.080)μg/L、34.000(25.000~75.000)μg/L、(4.000±1.560)ng/L]比较,差异有统计学意义(P<0.05)。(2)AMI组各指标单独检测阳性率高于非AMI组(P<0.05),联合检测的阳性率高于单项指标检测(P<0.05)。(3)cTnT、CK-MB、MYO、H-FABP的最佳诊断界值(Cut Off)分别为0.014 5μg/L、7.780 0μg/L、110.000 0μg/L、5.900 0ng/L。(4)cTnT、CK-MB、MYO、H-FABP单项及联合检测的临床诊断性能中,准确度最高的项目是cTnT(91.5%),灵敏度最高的项目是cTnT(89.3%),特异度最高的项目是cTnT(92.0%),阳性拟然比最高的项目是cTnT(11.2),阴性拟然比最低的项目是cTnT(0.12)。4项指标联合检测的诊断性能优于3项指标联合检测(P<0.05),并均高于各指标单项检测(P<0.05)。结论心肌损伤标志物在AMI诊断中具有重要的临床应用价值,各临床实验室应根据各自的检测条件确立适当的临床诊断界值。cTnT、CK-MB、MYO、H-FABP联合检测诊断性能均高于各单项指标,但单项指标各具优势,应根据临床对AMI的诊疗需求选择合适的联合或单项指标检测。 Objective To evaluate four common myocardial injury markers:cardiac troponin T(cTnT),creatine kinase MB isoenzyme(CK-MB),myoglobin(MYO),and heart-type fatty acid-binding protein(H-FABP)to the clinical diagnosis and treatment value of acute myocardial infarction(AMI).Methods A total of 200 patients(120 males and 80 females)who were admitted to hospital with main symptoms of"acute chest pain"were collected from January to December in 2017 in our hospital.ROC curves were used to evaluate the markers of myocardial injury alone and in combination of clinical diagnostic performance in AMI.Results(1)The levels of cTnT,CK-MB,MYO,and H-FABP in the AMI group were 0.162(0.027―0.457)μg/L,14.66(8.57―17.63)μg/L,149(68―234)μg/L,(6.33±1.99)ng/L,respectively.The levels of cTnT,CK-MB,MYO and H-FABP in non-AMI groups and were 0.007(0.005―0.010)μg/L and 1.65(1.22―3.08)μg/L,34(25―75)μg/L,(4.00±1.56)ng/L,respectively.The levels of cTnT,CK-MB,MYO and H-FABP were significantly different(P<0.05).(2)The positive rate of each indicator in the AMI group was higher than that in the non-AMI group(P<0.05).The positive rate of the combined test was higher than that of the single indicator.(3)Cut Off of cTnT,CK-MB,MYO and H-FABP were 0.014 5μg/L,7.780 0μg/L,110.000 0μg/L and 5.900 0 ng/L,respectively.(4)Among the clinical diagnostic performances of cTnT,CK-MB,MYO,H-FABP single and combined detection,the highest accuracy item was cTnT with 91.5%and the highest sensitivity was cTnT with 89.3%and the highest specificity was cTnT with 92.0%.The highest positive likelihood ratio items was cTnT,with 11.2,and the lowest negative likelihood ratio item was cTnT with 0.12.The four combined tests had the highest diagnostic performance than the three combined tests and each item.Conclusion Myocardial injury markers have important clinical application value in the diagnosis of AMI.Each clinical laboratory should establish the appropriate clinical diagnostic threshold according to their respective test conditions;cTnT,CK-MB,MYO,H-FABP combined detection diagnostic performance are all higher than the single detection of each item,but each individual item has its own advantages.It should be based on the clinical diagnosis and treatment needs of AMI to select appropriate combined tests or single item detection.
作者 钱净 李雪 杨丽琼 施茜 QIAN Jing;LI Xue;YANG Liqiong;SHI Qian(Department of Clinical Laboratory,the First People′s Hospital ofKunming,Kunming,Yunnan 650011,China;2015 Graduate Student, Kunming Medical University,Kunming,Yunnan 650011,China)
出处 《检验医学与临床》 CAS 2019年第1期31-34,共4页 Laboratory Medicine and Clinic
基金 云南省昆明市科技计划资助项目(2016-1-S-06793)
关键词 心肌损伤标志物 急性心肌梗死 受试者工作特征曲线 heart marker acute myocardial infarction receiver operating characteristic curve
  • 相关文献

参考文献4

二级参考文献76

  • 1张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2165
  • 3Pearson TA, Mensah GA, Hong Y, et al. CDC/AHA Workshop on markers of inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice : Overview. Circulation, 2004,110 : e543-544.
  • 4Myers GL,Rifai N,Tracy RP,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation ,200d, 110 :e545-549.
  • 5Smith SC Jr, Anderson JL, Cannon RO 3rd, et al. CDC/AHA Workshop on Markers of inflammation and Cardiovascular Disease:Application to Clinical And Public Health Practice: report from the clinical practice discussion group. Circulation,2004, 110 : e550-553.
  • 6Fortmann SP, Ford E, Criqui MH, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation,2004, 110 : e554-559.
  • 7Biasucci LM, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health practice: clinical use of inflammatory markers in Patients with cardiovascular diseases : a background paper.Circulation ,2004, 110 :e560-567.
  • 8Wilson PW, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation,2004,110:e568-571.
  • 9Roberts WL, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice. laboratory tests available to assess inflammation-performance and standardization: a background paper.Circulation, 2004,110 :e572-578.
  • 10Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation, 2003,108:250-252.

共引文献266

同被引文献376

引证文献41

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部